In this study, we disrupted PD-1 expression in cytotoxic T lymphocytes (CTLs) using CRISPR-Cas9 system and tested the anti-tumor effect of PD-1 knockout (KO) CTLs on multiple myeloma cells. This evidence concerns the gene PDCD1 and AL amyloidosis.